Significance of Marker Chromosome on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for AML

被引：0
|
作者：
Fuse, Kyoko
Masuko, Masayoshi
Mizuno, Shohei
Harada, Kaito
Uchida, Naoyuki
Doki, Noriko
Fukuda, Takahiro
Tanaka, Masatsugu
Ozawa, Yukiyasu
Ikegame, Kazuhiro
Eto, Tetsuya
Kanda, Yoshinobu
Ichinohe, Tatsuo
Atsuta, Yoshiko
Yanada, Masamitsu
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-138979
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Impact of Cytogenetics on Outcome of AML after Allogeneic Hematopoietic Stem Cell Transplantation
    Gindina, Tatiana L.
    Mamaev, Nikolay N.
    Afanasyev, Boris V.
    Bondarenko, Sergey N.
    Alyanskiy, Alexander
    Slesarchuk, Olga
    Moiseev, Ivan S.
    Razumova, Svetlana V.
    Zubarovskaya, Lyudmila
    [J]. BLOOD, 2015, 126 (23)
  • [2] Impact of comorbidity on the outcome of allogeneic hematopoietic stem cell transplantation in AML/MDS patients.
    Shahjahan, M
    Alamo, J
    Delima, M
    Khouri, I
    Gajewski, J
    Andersson, BS
    Champlin, RE
    Giralt, S
    [J]. BLOOD, 2003, 102 (11) : 708A - 708A
  • [3] The Impact of HLA Mismatch Direction on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in AML Patients
    Chen, Wen-Chun
    Gau, Jyh-Pyng, Sr.
    Hsiao, Liang-Tsai
    Liu, Chia-Jen
    Liu, Yao-Chung
    Wang, Hao-Yuan
    Ko, Po-Shen
    Liu, Jin-Hwang
    Chiou, Tzeon-Jye
    [J]. BLOOD, 2019, 134
  • [4] Graft Immune Cell Composition Associates with Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with AML
    Impola, Ulla
    Larjo, Antti
    Salmenniemi, Urpu
    Putkonen, Mervi
    Itala-Remes, Maija
    Partanen, Jukka
    [J]. FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [5] Significance of graft quality in allogeneic hematopoietic stem cell transplantation
    Jinca, Cristian
    Arghirescu, Smaranda
    Oprisoni, Andrada
    Balint-Gib, Loredana
    Baica, Mihaela
    Serban, Margit
    [J]. REVISTA ROMANA DE MEDICINA DE LABORATOR, 2009, 16 (03): : 21 - 27
  • [6] Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma
    H Shimizu
    T Saitoh
    M Tanaka
    T Mori
    T Sakura
    N Kawai
    Y Kanda
    C Nakaseko
    S Yano
    H Fujita
    S Fujisawa
    S Miyawaki
    H Kanamori
    S Okamoto
    [J]. Leukemia, 2012, 26 : 2469 - 2473
  • [7] Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma
    Shimizu, H.
    Saitoh, T.
    Tanaka, M.
    Mori, T.
    Sakura, T.
    Kawai, N.
    Kanda, Y.
    Nakaseko, C.
    Yano, S.
    Fujita, H.
    Fujisawa, S.
    Miyawaki, S.
    Kanamori, H.
    Okamoto, S.
    [J]. LEUKEMIA, 2012, 26 (12) : 2469 - 2473
  • [8] Allogeneic Hematopoietic Stem Cell Transplantation for Adult AML Patients with Granulocytic Sarcoma
    Shimizu, Hiroaki
    Saitoh, Takayuki
    Tanaka, Masatsugu
    Mori, Takehiko
    Kawai, Nobutaka
    Sakura, Toru
    Kanda, Yoshinobu
    Nakaseko, Chiaki
    Yano, Shingo
    Fujita, Hiroyuki
    Fujisawa, Shin
    Miyawaki, Shuichi
    Kanamori, Heiwa
    Okamoto, Shinichiro
    [J]. BLOOD, 2011, 118 (21) : 890 - 891
  • [9] Generalist in allogeneic hematopoietic stem cell transplantation for MDS or AML: Epigenetic therapy
    Yang, Guancui
    Wang, Xiang
    Huang, Shiqin
    Huang, Ruihao
    Wei, Jin
    Wang, Xiaoqi
    Zhang, Xi
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [10] Transcriptional Immunoediting of AML Cells after Allogeneic Hematopoietic Stem Cell Transplantation
    Eagle, Kenneth
    Harada, Taku
    Kalfon, Jeremie
    Perez, Monika
    Heshmati, Yaser
    Ewers, Jazmin
    Stegmaier, Kimberly
    Orkin, Stuart H.
    Pimkin, Maxim
    [J]. BLOOD, 2021, 138
12345